lucinactant
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction:A lyophilized formulation of lucinactant has been developed to simplify preparation and dosing. Endotracheal…
Reducing neonatal mortality in developing countries: low-cost interventions are the key determinants
Recent FDA action (through June 2009) related to lucinactant, fenretinide, fampridine-SR, HPN-100, vitespen, and prodarsan
Exogenous surfactant is critical in the treatment of neonates with respiratory distress syndrome. Lucinactant (Surfaxin…
Background: Surfactant replacement therapy (SRT) has been demonstrated to be both safe and highly effective in the treatment of…
Development and validation of a gradient, reversed-phase HPLC-CAD method simultaneously determining all protein, lipid and lipid…
BACKGROUND. Animal-derived, protein-containing surfactants seem to be superior to protein-free surfactants. Lucinactant, a…
OBJECTIVE
The use of exogenous surfactants among preterm infants for the prevention and treatment of respiratory distress…
Surfaxin® (lucinactant), a peptide‐based surfactant consisting of dipalmitoylphosphatidylcholine (DPPC) plus KL4 (sinapultide) (a…
Introduction: Supine sleeping is recommended to prevent sudden infant death syndrome (SIDS). Anecdotal evidence, however…